Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New ROCK inhibitor developed at Inspire for the treatment of ocular hypertension

May 8, 2008

PCI-27483 active against lung and pancreatic cancer in vivo

May 8, 2008

ANG-1005 allows transport of paclitaxel to the brain

May 8, 2008

Thapsigargin analogue developed as a treatment for cancer

May 8, 2008

GSK-690693 safe, inhibits AKT in a first-in-human study

May 8, 2008

TG-100801's clinical evaluation discontinued due to phase IIa results

May 7, 2008

Antennapedia Trojan peptide-p21 fusion protein inhibits tumor cell growth

May 7, 2008

Positive preclinical data of Palomid-529 in models of ocular disorders

May 7, 2008

F-14512 activity depends on polyamine transport system status of tumors

May 7, 2008

Serenex describes discovery of SNX-5422, an Hsp90 inhibitor in phase I development

May 7, 2008

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...